ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1491

Self-Reported Cognitive Function Among Older Adults with Systemic Lupus Erythematosus (SLE) Compared to Older Adults with Other Rheumatic and Musculoskeletal Conditions

Patti Katz1, Sofia Pedro2 and Kaleb Michaud3, 1UCSF, San Rafael, CA, 2Forward, The National Databank for Rheumatic Diseases, Wichita, KS, 3University of Nebraska Medical Center, Omaha, NE

Meeting: ACR Convergence 2024

Keywords: Cognitive dysfunction, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 17, 2024

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Cognitive symptoms such as forgetfulness or “brain fog” are frequently reported in SLE and among the most distressing symptoms of lupus. Cognitive symptoms are also commonly reported among older adults, but little information is available about cognitive symptoms in older people with SLE compared to those of similar ages with other rheumatic or musculoskeletal conditions.  We compared self-reported cognitive function among an older adult cohort with SLE to individuals with rheumatoid arthritis (RA), osteoarthritis (OA), and fibromyalgia (FM) of similar ages, and examined the association of cognitive function with self-perceptions of health status and functioning.

Methods: Data were from FORWARD, The National Databank for Rheumatic Diseases, a longitudinal observational cohort.  Data are collected biannually via questionnaires.  Individuals with physician-diagnosed SLE, RA, OA, and FM age≥55 were included in analyses. Cognitive symptoms were assessed in 3 biannual surveys with the 8-item NeuroQoL Cognitive Function Short Form (NCF)1, which queries cognitive symptoms and perceived ability to complete everyday tasks.  We compared scores of individuals with SLE and no other rheumatic diagnosis to individuals with RA, OA, FM, and SLE + FM using generalized estimating equation (GEE) modeling, adjusting for age, education, pain, fatigue, sleep disturbance, and depressive symptoms.  Among the SLE-only group, we compared self-reported lupus disease activity (0-10 scale, 0 = not at all active, 10 = extremely active), organ damage (Brief Index of Lupus Damage, BILD), and the occurrence of flares in the past 3 months between those with low NCF T-scores (below 40, i.e., 1 SD below mean) and those with higher scores.  We also compared global health rating (0 – 100), health satisfaction (5-point scale, 0 = very satisfied, 4 = very dissatisfied), and social and role functioning (from SF-36) for those with and without low NCF scores, adjusting for age, education, pain, fatigue, sleep disturbance, depressive symptoms, self-rated lupus activity, and BILD.

Results: 125 SLE, 6135 RA, 995 OA, 254 FM, and 41 SLE+FM questionnaires from respondents ≥ age 55 were completed over 3 periods.  Characteristics of each group are shown in Table 1.  After adjustment, NCF scores of individuals with SLE alone and SLE +FM were significantly lower than other groups (Table 2).  Over a quarter of the SLE group and almost half of the SLE + FM had low NCF scores (Table 2).  In the SLE-only group, low NCF scores were associated with significantly higher self-reported disease damage, greater occurrence of flares, and worse global health, health satisfaction, and social and role functioning (Table 3).

Conclusion: Cognitive symptoms are significantly worse among older individuals with SLE compared to individuals of similar age with other rheumatic or musculoskeletal conditions.  Results show that the burden of cognitive symptoms continues into older age for individuals with SLE, is significantly greater than for older individuals with other rheumatic/musculoskeletal conditions, and has an important impact on quality of life, above and beyond lupus disease status. 

Reference

1Iverson GL et al. Arch Clin Neuropsychol 2021; 36:126-134

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: P. Katz: None; S. Pedro: None; K. Michaud: None.

To cite this abstract in AMA style:

Katz P, Pedro S, Michaud K. Self-Reported Cognitive Function Among Older Adults with Systemic Lupus Erythematosus (SLE) Compared to Older Adults with Other Rheumatic and Musculoskeletal Conditions [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/self-reported-cognitive-function-among-older-adults-with-systemic-lupus-erythematosus-sle-compared-to-older-adults-with-other-rheumatic-and-musculoskeletal-conditions/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/self-reported-cognitive-function-among-older-adults-with-systemic-lupus-erythematosus-sle-compared-to-older-adults-with-other-rheumatic-and-musculoskeletal-conditions/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology